Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump
Frontiers in Cardiovascular Medicine · 18.07.2023 · 10
DOI: 10.3389/fcvm.2023.1185261 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 18.07.2023. Verfasst von Changwon Kho. Beteiligte Einrichtung: Division of Applied Medicine, School of Korean Medicine, Pusan National University, Yangsan, Republic of Korea. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Impaired myocardial Ca 2+ cycling is a critical contributor to the development of heart failure (HF), causing changes in the contractile function and structure remodeling of the heart. Within cardiomyocytes, the regulation of sarcoplasmic reticulum (SR) Ca 2+ storage and release is largely dependent on Ca 2+ handling proteins, such as the SR Ca 2+ ATPase (SERCA2a) pump. During the relaxation phase of the cardiac cycle (diastole), SERCA2a plays a critical role in transporting cytosolic Ca 2+ back to the SR, which helps to restore both cytosolic Ca 2+ levels to their resting state and SR Ca 2+ content for the next contraction. However, decreased SERCA2a expression and/or pump activity are key features in HF. As a result, there is a growing interest in developing therapeutic approaches to target SERCA2a. This review provides an overview of the regulatory mechanisms of the SERCA2a pump and explores potential strategies for SERCA2a-targeted therapy, which are being investigated in both preclinical and clinical studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Applied Medicine, School of Korean Medicine, Pusan National University, Yangsan, Republic of Korea.
Zitieren
APA
Kho, C. (2023). Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1185261
Vancouver
Kho C. Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1185261
BibTeX
@article{Kho2023,
author = {Kho, Changwon},
title = {Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1185261}
}
EUVIMED